[House-dust mites allergen for specific immunotherapy by oral administration: experimental study]

Area of Science:

• Allergen immunotherapy
• Pharmaceutical technology
• Immunology

Context:

• House dust mites (Dermatophagoides farinae) are a primary cause of allergic respiratory diseases.
• Current immunotherapy options often involve injections or sublingual routes.
• Developing stable, orally administered allergens is crucial for improving patient compliance and accessibility.

Purpose:

• To develop and characterize a novel oral medicinal form of house-dust mite allergen.
• To assess the chemical stability, biological activity, microbiological purity, and safety of the oral allergen preparation.
• To evaluate the immunogenicity and allergenicity profile of the new preparation.

Summary:

• A stable oral house-dust mite allergen preparation was developed using a standard water-saline extract of Dermatophagoides farinae.
• The preparation exhibits microbiological purity suitable for oral administration and maintains biological activity for 2-3 years.
• Immunochemical analysis revealed high immunogenicity and low allergenicity, with no observed chronic toxicity during prolonged administration studies.

Impact:

• This novel oral allergen preparation shows promise as a safe and effective option for house dust mite allergy immunotherapy.
• The preparation's stability and ease of administration could enhance patient adherence to treatment.
• Findings support the recommendation of this preparation for further clinical trials in a controlled setting.